11.62
전일 마감가:
$11.85
열려 있는:
$11.86
하루 거래량:
2.13M
Relative Volume:
0.79
시가총액:
$2.91B
수익:
$496.43M
순이익/손실:
$71.35M
주가수익비율:
40.79
EPS:
0.2849
순현금흐름:
$151.57M
1주 성능:
+0.00%
1개월 성능:
-21.22%
6개월 성능:
-13.93%
1년 성능:
-28.97%
셀러브라이트 Stock (CLBT) Company Profile
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CLBT
Cellebrite Di Ltd
|
11.62 | 2.84B | 496.43M | 71.35M | 151.57M | 0.2849 |
|
MSFT
Microsoft Corp
|
496.82 | 3.57T | 318.27B | 125.22B | 72.92B | 16.79 |
|
ORCL
Oracle Corp
|
145.75 | 409.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
|
PLTR
Palantir Technologies Inc
|
169.46 | 418.04B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
CRWD
Crowdstrike Holdings Inc
|
203.42 | 193.82B | 5.09B | -24.89M | 1.43B | -0.0471 |
|
FTNT
Fortinet Inc
|
154.54 | 110.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
셀러브라이트 Stock (CLBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-28 | 재확인 | Needham | Buy |
| 2024-03-13 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-07-19 | 개시 | Craig Hallum | Buy |
| 2022-08-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | 개시 | JP Morgan | Overweight |
| 2022-02-11 | 개시 | Deutsche Bank | Buy |
| 2021-12-02 | 개시 | BofA Securities | Buy |
| 2021-10-21 | 개시 | Citigroup | Buy |
모두보기
셀러브라이트 주식(CLBT)의 최신 뉴스
Cellebrite (CLBT): CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains - Yahoo Finance
Kaplan Fox Launches Securities Probe into Cellebrite DI Ltd (CLBT) Following 29% Stock Plunge and CEO Replacement - Kalkine Media
Cellebrite DI Ltd (CLBT) Faces Securities Investigation After 29% Stock Drop and CEO Change - kalkine.ca
Cellebrite Genesis expands to UK & Australia - SourceSecurity.com
Cellebrite shares plunge over 30% after Q2 reve... - Pluang
Cellebrite DI Ltd. (CLBT) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Cellebrite Genesis AI Solutions Expand Globally | Security News - Security Informed
Cellebrite (CLBT) Q2 2026 Earnings Call Transcript - The Globe and Mail
Kaplan Fox Announces an Investigation Into Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets - Japan Wire by Kyodo News
Cellebrite’s New CEO Resets 2026 Outlook After Record 2025 and Calls September Shareholder Meeting - The Globe and Mail
Cellebrite expands Genesis AI tool to enterprise market By Investing.com - Investing.com South Africa
Cellebrite faces securities probe after missing revenue targets and sudden CEO change. - Pluang
Cellebrite DI (CLBT) Stock Falls 29% After ARR Miss and CEO Change, Sparking Securities Investigation - kalkine.ca
Cellebrite DI Says Genesis Platform Now Available to Enterprises, Expands Globally - marketscreener.com
Cellebrite Di Ltd Cellebrite Genesis Is Expanding To More Global Markets And Is Now Generally Available For Enterprise Organizations - TradingView
Cellebrite expands Genesis platform to enterprise and new markets - StreetInsider
Cellebrite (CLBT) officer sets 2026 sell-to-cover for 5,673 shares - Stock Titan
Cellebrite (NASDAQ: CLBT) officer plans tax-driven share sale - Stock Titan
Cellebrite Genesis Expands to Global Markets - Intellectia AI
Cellebrite DI Ltd (CLBT) Stock News Today - TradingKey
Cellebrite (CLBT) Quarterly Figures: Profit Per Share Falls Below Its Benchmark in the Latest Reading; Reaction Snapshot: Shares Finish 5.36% Up at the ClosePre-Announcement Alert - Vinanet
Cellebrite Genesis Expands Internationally - Intellectia AI
Voss Capital reports new stake in Cellebrite (NASDAQ: CLBT) - Stock Titan
Cellebrite (NASDAQ: CLBT) lowers 2026 forecast amid vote on CEO equity plan - Stock Titan
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Possible Securities Law Violations - The National Law Review
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI Ltd. (CLBT) - GlobeNewswire
Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating - Yahoo Finance
Cellebrite DI Ltd. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:CLBT) 2026-08-17 - Seeking Alpha
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 6.2% Following Analyst Downgrade - MarketBeat
Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition - simplywall.st
Cellebrite DI Is Maintained at Buy by DA Davidson - Moomoo
Cellebrite DI Ltd (CLBT) Stock Up 3.1% and Still Undervalued -- GF Score: 84/100 - GuruFocus
Can Cellebrite DI (NASDAQ:CLBT) Regain Market Confidence? - Kalkine Media
Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools - simplywall.st
Cellebrite Announces CEO Transition to Shiven Ramji in Planned Succession - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Given New $15.00 Price Target at Lake Street Capital - MarketBeat
CLBT|Cellebrite DI Ltd|Price:11.110|Chg%:+0.310 - TradingKey
Cellebrite Plunges 29% as New CEO Ramji Slashes 2026 Revenue Outlook - finance.biggo.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Legal Tech Roundup: Cellebrite, LexisNexis - Law360
Cellebrite DI (NASDAQ:CLBT) Sees Unusually-High Trading Volume After Strong Earnings - MarketBeat
DA Davidson Has Lowered Expectations for Cellebrite DI (NASDAQ:CLBT) Stock Price - MarketBeat
Cellebrite DI Ltd. (CLBT) Edges Higher on Steady Demand for Digital Intelligence SolutionsIchimoku Cloud - Vinanet
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap? - Yahoo Finance
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd. - PR Newswire
Cellebrite DI (NASDAQ:CLBT) Given New $12.50 Price Target at Needham & Company LLC - MarketBeat
Needham cuts Cellebrite stock price target on guidance reduction By Investing.com - Investing.com South Africa
Needham cuts Cellebrite stock price target on guidance reduction - Investing.com
셀러브라이트 (CLBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
셀러브라이트 주식 (CLBT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| GEE DAVID NICHOLAS | Chief Marketing Officer |
Aug 24 '26 |
Sale |
11.36 |
4,323 |
49,111 |
135,281 |
자본화:
|
볼륨(24시간):